CACNA1C and polyostotic fibrous dysplasia: In addition, treating cardiac myocytes with PFD (1–2 days) induces a substantial increase in the activity of CaV1.2, by a TGF-β1 independent mechanism (Ramos-Mondragón et al., 2012).